144 related articles for article (PubMed ID: 37824705)
1. Foldback-crRNA-Enhanced CRISPR/Cas13a System (FCECas13a) Enables Direct Detection of Ultrashort sncRNA.
Chen Y; Zhang Y; Luo S; Yang X; Liu C; Zhang Q; Liu Y; Zhang X
Anal Chem; 2023 Oct; 95(42):15606-15613. PubMed ID: 37824705
[TBL] [Abstract][Full Text] [Related]
2. Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme.
Knott GJ; East-Seletsky A; Cofsky JC; Holton JM; Charles E; O'Connell MR; Doudna JA
Nat Struct Mol Biol; 2017 Oct; 24(10):825-833. PubMed ID: 28892041
[TBL] [Abstract][Full Text] [Related]
3. Specific High-Sensitivity Enzymatic Molecular Detection System Termed RPA-Based CRISPR-Cas13a for Duck Tembusu Virus Diagnostics.
He D; Liu G; Yang J; Jiang X; Wang H; Fan Y; Gong S; Wei F; Diao Y; Tang Y
Bioconjug Chem; 2022 Jun; 33(6):1232-1240. PubMed ID: 35586918
[TBL] [Abstract][Full Text] [Related]
4. RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.
Tambe A; East-Seletsky A; Knott GJ; Doudna JA; O'Connell MR
Cell Rep; 2018 Jul; 24(4):1025-1036. PubMed ID: 30044970
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
[TBL] [Abstract][Full Text] [Related]
6. Programming the
Liu X; Kang X; Lei C; Ren W; Liu C
Anal Chem; 2022 Mar; 94(9):3987-3996. PubMed ID: 35193353
[TBL] [Abstract][Full Text] [Related]
7. Improving trans-cleavage activity of CRISPR-Cas13a using engineered crRNA with a uridinylate-rich 5'-overhang.
Yang Y; Sun L; Zhao J; Jiao Y; Han T; Zhou X
Biosens Bioelectron; 2024 Jul; 255():116239. PubMed ID: 38552526
[TBL] [Abstract][Full Text] [Related]
8. High-Fidelity and Rapid Quantification of miRNA Combining crRNA Programmability and CRISPR/Cas13a trans-Cleavage Activity.
Shan Y; Zhou X; Huang R; Xing D
Anal Chem; 2019 Apr; 91(8):5278-5285. PubMed ID: 30873832
[TBL] [Abstract][Full Text] [Related]
9. A rapid and efficient platform for antiviral crRNA screening using CRISPR-Cas13a-based nucleic acid detection.
Yang L; Zhang Y; Yi W; Dong X; Niu M; Song Y; Han Y; Li H; Sun Y
Front Immunol; 2023; 14():1116230. PubMed ID: 37228594
[TBL] [Abstract][Full Text] [Related]
10. A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.
Meeske AJ; Jia N; Cassel AK; Kozlova A; Liao J; Wiedmann M; Patel DJ; Marraffini LA
Science; 2020 Jul; 369(6499):54-59. PubMed ID: 32467331
[TBL] [Abstract][Full Text] [Related]
11. Universal theranostic CRISPR/Cas13a RNA-editing system for glioma.
Wu Y; Wang Y; Zhou J; Wang J; Zhan Q; Wang Q; Yang E; Jin W; Tong F; Zhao J; Hong B; Liu J; Kang C
Theranostics; 2023; 13(15):5305-5321. PubMed ID: 37908718
[No Abstract] [Full Text] [Related]
12. Tetrahedron supported CRISPR/Cas13a cleavage for electrochemical detection of circular RNA in bladder cancer.
Cheng L; Yang F; Zhao Y; Liu Z; Yao X; Zhang J
Biosens Bioelectron; 2023 Feb; 222():114982. PubMed ID: 36493719
[TBL] [Abstract][Full Text] [Related]
13. Electrochemical biosensor for nucleic acid amplification-free and sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA via CRISPR/Cas13a trans-cleavage reaction.
Heo W; Lee K; Park S; Hyun KA; Jung HI
Biosens Bioelectron; 2022 Apr; 201():113960. PubMed ID: 35016109
[TBL] [Abstract][Full Text] [Related]
14. The CRISPR-Cas13a Gemini System for noncontiguous target RNA activation.
Zhao H; Sheng Y; Zhang T; Zhou S; Zhu Y; Qian F; Liu M; Xu W; Zhang D; Hu J
Nat Commun; 2024 Apr; 15(1):2901. PubMed ID: 38575571
[TBL] [Abstract][Full Text] [Related]
15. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
16. Target-induced transcription amplification to trigger the trans-cleavage activity of CRISPR/Cas13a (TITAC-Cas) for detection of alkaline phosphatase.
Wang X; Zhou S; Chu C; Yang M; Huo D; Hou C
Biosens Bioelectron; 2021 Aug; 185():113281. PubMed ID: 33940494
[TBL] [Abstract][Full Text] [Related]
17. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical self-uncloaking CRISPR-Cas13a-customized RNA nanococoons for spatial-controlled genome editing and precise cancer therapy.
Fan N; Bian X; Li M; Chen J; Wu H; Peng Q; Bai H; Cheng W; Kong L; Ding S; Li S; Cheng W
Sci Adv; 2022 May; 8(20):eabn7382. PubMed ID: 35584220
[TBL] [Abstract][Full Text] [Related]
19. Massively parallel profiling of RNA-targeting CRISPR-Cas13d.
Kuo HC; Prupes J; Chou CW; Finkelstein IJ
Nat Commun; 2024 Jan; 15(1):498. PubMed ID: 38216559
[TBL] [Abstract][Full Text] [Related]
20. Dual Methylation-Sensitive Restriction Endonucleases Coupling with an RPA-Assisted CRISPR/Cas13a System (DESCS) for Highly Sensitive Analysis of DNA Methylation and Its Application for Point-of-Care Detection.
Wang X; Zhou S; Chu C; Yang M; Huo D; Hou C
ACS Sens; 2021 Jun; 6(6):2419-2428. PubMed ID: 34019391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
